✦ LIBER ✦

The utility of salivary amylase as an evaluation of M3 muscarinic agonist activity in alzheimer's disease

✍ Scribed by John J. Sramek; Neal R. Cutler1; Daniel J. Hurley; Randall D. Seifert1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The utility of muscarinic agonists in th

✍ William S. Messer 📂 Article 📅 2002 🏛 Humana Press Inc 🌐 English ⚖ 98 KB

M1muscarinic agonists can modulate some

✍ Abraham Fisher; Zipora Pittel; Rachel Haring; Nira Bar-Ner; Michal Kliger-Spatz; 📂 Article 📅 2003 🏛 Humana Press Inc 🌐 English ⚖ 332 KB

182 The effects of xanomeline, an M1-sel

✍ N. Bodick; W. Offen; K. Rasmussen; S. Paul 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 122 KB

Novel m1 muscarinic agonists in treatmen

✍ Abraham Fisher; Rachel Brandeis; Rachel Haring; Naomi Eshhar; Eliahu Heldman; Yi 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 366 KB

Use of an M1/M4-selective muscarinic ago

✍ Hanson, Seth A.; Verdone, Melinda L.; Hendrickson, Michael L.; Ockuly, Jeffrey C 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 40 KB

P2-448: Preclinical evaluation of CDD-01

✍ Messer, William S.; Steinmetz, Karen; Parman, Toufan; Catz, Paul; Green, Carol; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 53 KB